542 related articles for article (PubMed ID: 16940865)
1. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
Green S; Rothman A
Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
[TBL] [Abstract][Full Text] [Related]
2. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
Fink J; Gu F; Vasudevan SG
Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
[TBL] [Abstract][Full Text] [Related]
3. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte responses to heterologous secondary dengue virus infections.
Rothman AL
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400
[TBL] [Abstract][Full Text] [Related]
5. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever.
Huang JH; Wey JJ; Sun YC; Chin C; Chien LJ; Wu YC
J Med Virol; 1999 Jan; 57(1):1-8. PubMed ID: 9890415
[TBL] [Abstract][Full Text] [Related]
7. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
Melino S; Paci M
FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
[TBL] [Abstract][Full Text] [Related]
8. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever.
Wang WK; Chen HL; Yang CF; Hsieh SC; Juan CC; Chang SM; Yu CC; Lin LH; Huang JH; King CC
Clin Infect Dis; 2006 Oct; 43(8):1023-30. PubMed ID: 16983615
[TBL] [Abstract][Full Text] [Related]
9. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.
Libraty DH; Young PR; Pickering D; Endy TP; Kalayanarooj S; Green S; Vaughn DW; Nisalak A; Ennis FA; Rothman AL
J Infect Dis; 2002 Oct; 186(8):1165-8. PubMed ID: 12355369
[TBL] [Abstract][Full Text] [Related]
10. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation.
Cheng HJ; Lei HY; Lin CF; Luo YH; Wan SW; Liu HS; Yeh TM; Lin YS
Mol Immunol; 2009 Dec; 47(2-3):398-406. PubMed ID: 19822367
[TBL] [Abstract][Full Text] [Related]
11. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
Mongkolsapaya J; Dejnirattisai W; Xu XN; Vasanawathana S; Tangthawornchaikul N; Chairunsri A; Sawasdivorn S; Duangchinda T; Dong T; Rowland-Jones S; Yenchitsomanus PT; McMichael A; Malasit P; Screaton G
Nat Med; 2003 Jul; 9(7):921-7. PubMed ID: 12808447
[TBL] [Abstract][Full Text] [Related]
12. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
[TBL] [Abstract][Full Text] [Related]
13. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever.
Ubol S; Masrinoul P; Chaijaruwanich J; Kalayanarooj S; Charoensirisuthikul T; Kasisith J
J Infect Dis; 2008 May; 197(10):1459-67. PubMed ID: 18444802
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency.
Chen MC; Lin CF; Lei HY; Lin SC; Liu HS; Yeh TM; Anderson R; Lin YS
J Immunol; 2009 Aug; 183(3):1797-803. PubMed ID: 19592650
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.
Beaumier CM; Mathew A; Bashyam HS; Rothman AL
J Infect Dis; 2008 Feb; 197(4):608-17. PubMed ID: 18275279
[TBL] [Abstract][Full Text] [Related]
16. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
[TBL] [Abstract][Full Text] [Related]
17. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.
Avirutnan P; Punyadee N; Noisakran S; Komoltri C; Thiemmeca S; Auethavornanan K; Jairungsri A; Kanlaya R; Tangthawornchaikul N; Puttikhunt C; Pattanakitsakul SN; Yenchitsomanus PT; Mongkolsapaya J; Kasinrerk W; Sittisombut N; Husmann M; Blettner M; Vasanawathana S; Bhakdi S; Malasit P
J Infect Dis; 2006 Apr; 193(8):1078-88. PubMed ID: 16544248
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.
Appanna R; Huat TL; See LL; Tan PL; Vadivelu J; Devi S
Clin Vaccine Immunol; 2007 Aug; 14(8):969-77. PubMed ID: 17567768
[TBL] [Abstract][Full Text] [Related]
19. Understanding dengue pathogenesis: implications for vaccine design.
Stephenson JR
Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
[TBL] [Abstract][Full Text] [Related]
20. Immunopathogenesis of Dengue hemorrhagic fever.
Rothman AL; Ennis FA
Virology; 1999 Apr; 257(1):1-6. PubMed ID: 10208914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
